GenSci144 Tablets Phase I Clinical Trial
3d agoen
From the article
Conditions : Phenylketonuria Interventions : Drug: GenSci144 tablets; Drug: GenSci144 placebo tablets Sponsors : Changchun GeneScience Pharmaceutical Co., Ltd. Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment
GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration, a theranostics study aimed at developing a more personalized
mayocl.in·15h ago
FDA Clears NIH-Supported Gene Therapy MMA-101 for First Human Trial in Rare Metabolic Disorder
The FDA has cleared an Investigational New Drug (IND) application for MMA-101, an AAV-based gene therapy candidate developed with NIH suppor
ncats.nih.gov·9d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.